Cover Image
市場調查報告書

神經性食慾不振症:全球臨床實驗趨勢

Anorexia Nervosa Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 235311
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
神經性食慾不振症:全球臨床實驗趨勢 Anorexia Nervosa Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月31日 內容資訊: 英文 84 Pages
簡介

本報告提供神經性食慾不振症臨床實驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,並彙整進行臨床實驗的主要製藥企業及研究機關簡介等資料。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量:亞太地區
    • 前五名國家的臨床實驗數量:歐洲
    • 主要國家的臨床實驗數量:北美
    • 主要國家的臨床實驗數量:中東/非洲地區

G7各國的臨床實驗數量:神經性食慾不振症臨床實驗數量佔中樞神經系統臨床實驗數量比率

各期臨床實驗數量:G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:神經性食慾不振症臨床實驗數量佔中樞神經系統臨床實驗數量比率

各期臨床實驗數量:E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 神經性食慾不振症治療藥

有潛力的藥劑

最新臨床實驗新聞:神經性食慾不振症

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Anorexia Nervosa Global Clinical Trials Review, H1, 2017" provides an overview of Anorexia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Anorexia Nervosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Anorexia Nervosa to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Anorexia Nervosa to Central Nervous System Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 27
  • Subjects Recruited Over a Period of Time 28
  • Clinical Trials by Sponsor Type 29
  • Prominent Sponsors 30
  • Top Companies Participating in Anorexia Nervosa Therapeutics Clinical Trials 32
  • Prominent Drugs 34
  • Clinical Trial Profile Snapshots 36

Appendix 84

  • Abbreviations 84
  • Definitions 84
  • Research Methodology 85
  • Secondary Research 85
  • About GlobalData 86
  • Contact Us 86
  • Source 87

List of Tables

List of Tables

  • Anorexia Nervosa Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Anorexia Nervosa Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Anorexia Nervosa Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Anorexia Nervosa Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Anorexia Nervosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Anorexia Nervosa to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Anorexia Nervosa Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Anorexia Nervosa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Anorexia Nervosa to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 19
  • Anorexia Nervosa Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
  • Anorexia Nervosa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials by Phase, 2017* 23
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
  • Anorexia Nervosa Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
  • Anorexia Nervosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
  • Anorexia Nervosa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
  • Anorexia Nervosa Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
  • Anorexia Nervosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
  • Anorexia Nervosa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

List of Figures

List of Figures

  • Anorexia Nervosa Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Anorexia Nervosa Therapeutics, Global, Clinical Trials In
Back to Top